Lin, R Y <br/><br/>
Intravenous gammaglobulin-associated renal impairment reported to the FDA: 2004 - 2009.  [electronic resource] 

 -  Clinical nephrology  Nov 2011 
 - 365-72 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0301-0430 
<br/><br/><label>Standard No.: </label>10.5414/cn106824  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adverse Drug Reaction Reporting Systems<br/>Chi-Square Distribution<br/>Female<br/>Humans<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Kidney Diseases--chemically induced<br/>Logistic Models<br/>Male<br/>Risk Factors<br/>United States--epidemiology<br/>United States Food and Drug Administration<br/>gamma-Globulins--administration & dosage